Loading…
Stability characterization of controlled release coprecipitates and solid dispersions
The present study was conducted to determine the effects of ageing at exaggerated storage conditions on controlled release tablets prepared with indomethacin–Eudragit® coprecipitates (CPs) and solid dispersions (SDs). CPs and SDs compressed as tablets were stored at −20, 4, 37, 45, 55, 37°C/11% RH,...
Saved in:
Published in: | Journal of controlled release 2000-01, Vol.63 (1-2), p.1-6 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The present study was conducted to determine the effects of ageing at exaggerated storage conditions on controlled release tablets prepared with indomethacin–Eudragit® coprecipitates (CPs) and solid dispersions (SDs). CPs and SDs compressed as tablets were stored at −20, 4, 37, 45, 55, 37°C/11% RH, 37°C/51% RH and 37°C/91% RH. The samples were analyzed over a period of six months for their dissolution, crystalline reversion and thermal changes. Samples stored at extremely low temperatures, higher temperatures and humidity conditions exhibited a significant decrease in dissolution rates. However, no significant change in the release rates was observed for samples stored at 4°C. The degree of crystallinity increased over a period of time as confirmed by X-ray diffractometry. DSC data demonstrated that indomethacin exists in two polymorphic forms, Form I (mp 160–161°C) and Form II (mp 153–154°C). CPs showed an endotherm of Form I, whereas SDs showed a mixture of Form I and II. |
---|---|
ISSN: | 0168-3659 1873-4995 |
DOI: | 10.1016/S0168-3659(99)00172-8 |